Nomura Micro Science Co., Ltd.

$ 4 805.00 -5.23 %

Nomura Micro Science Co., Ltd. specializes in water treatment technology, offering design, installation, and sales services across Japan, South Korea, Taiwan, China, and the United States. The company delivers a broad spectrum of water treatment facilities and apparatus, encompassing pure and ultra-pure water systems, pharmaceutical-grade water production, wastewater processing, and water reclamation solutions. Their extensive equipment range includes pretreatment systems, heat-regenerative membrane filtration, coagulation sedimentation, various filtration types (flocculation, gravity, pressure), electrodeionization, ion exchange, reverse osmosis (RO) systems, vacuum and membrane degasifiers, pure steam generators, packaged purified water systems, WFI production, ozone and hydrogen water systems, and anti-static equipment. Additionally, they supply components such as return contamination and H2O2 monitors, nuclepore membranes, filter cartridges, and essential piping and environmental materials. Nomura Micro Science also provides contract services for on-site pure water supply, along with comprehensive water analysis and evaluation. Their solutions cater to a diverse client base across industries including electronics, pharmaceuticals, biotechnology, food, environmental management, energy, and analytical sectors. Founded in 1969, the company is headquartered in Atsugi, Japan.

CEO: Makoto Uchida - https://www.nomura-nms.co.jp

Price objectif

-

Recommandation

-

DCF

$ -333.25

Loading data...

6254.T vs S&P500

Loading data...

No data available.

Quick ratio

1.39

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

48.78

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

98.50

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

10.16 %

reflects reasonable profitability, showing good use of equity.

ROIC

4.83 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.63

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.33

means it relies more on debt, which can increase financial risk.

Free cash flow per share

0.00

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
4 indicates moderate financial health
Altman score
3.01 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.15 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.48 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.